Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 6;12(1):16761.
doi: 10.1038/s41598-022-20994-y.

Effect of a single vectored thermal pulsation treatment of Meibomian gland dysfunction patients under controlled environmental conditions

Affiliations

Effect of a single vectored thermal pulsation treatment of Meibomian gland dysfunction patients under controlled environmental conditions

Andrea Novo-Diez et al. Sci Rep. .

Abstract

To assess the prophylactic effect of LipiFlow treatment in Meibomian gland dysfunction (MGD) patients exposed to an adverse environmental humidity. MGD patients were exposed to normal (23 °C; 50% relative humidity; 30 min) and adverse (23 °C; 10% relative humidity; 2 h) controlled environments consecutively during baseline and follow-up visits (3, 6, and 12 months) after a single LipiFlow treatment. Ocular Surface Disease Index (OSDI), lipid layer thickness (LLT), fluorescein tear break-up time (TBUT), corneal and conjunctival staining, change in dry eye symptoms questionnaire (CDES-Q), and Meibomian gland yielding liquid secretion (MGYLS), were assessed. Linear mixed-effects and cumulative logit mixed models were fitted to assess the effect of the LipiFlow treatment over time and within the controlled environments. Seventeen females and 4 males (59.6 ± 9.4 years) completed the study. LLT and TBUT did not vary significantly (p > 0.05) after LipiFlow treatment. OSDI, corneal and conjunctival staining, and MGYLS scores were improved (p ≤ 0.01) 12 months after treatment. After the adverse exposure, corneal staining increased at all visits (p = 0.01), and there was no significant improvement in CDES-Q scores after LipiFlow treatment (p ≥ 0.07). One LipiFlow treatment improved objective and subjective outcomes in MGD disease for at least one year. Further studies are needed to support that LipiFlow might also help as an adjuvant to avoid acute flares against an adverse environmental humidity.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Chronological scheme of the tests performed at each visit. OSDI = ocular surface disease index, BCVA = best corrected visual acuity, MGYLS = meibomian gland yielding liquid secretion, LLT = lipid layer thickness, TBUT = tear break-up time, MG = Meibomian glands, CDES-Q = change in dry eye symptoms questionnaire.
Figure 2
Figure 2
Fluorescein corneal staining. Scores based on the Cornea and Contact Lens Research Unit (CCLRU) scale were determined at baseline and at the 3-, 6-, and 12-month follow-up visits, before and after the exposure to the adverse controlled environment. Mean values and confidence interval error bars are represented. Grey bars represent comparisons between visits during exposure to the normal environment. *p = 0.0314, **p = 0.0001, ***p < 0.0001. The adverse environmental exposure had a significant (p = 0.0165) negative effect on corneal staining regardless of the visit. The interaction between the effect of the time and the conditions was not significant (p = 0.49).

Similar articles

Cited by

References

    1. Schaumberg DA, et al. The international workshop on meibomian gland dysfunction: Report of the subcommittee on the epidemiology of, and associated risk factors for, MGD. Investig. Ophthalmol. Vis. Sci. 2011;52:1994–2005. - PMC - PubMed
    1. Nelson JD, et al. The international workshop on meibomian gland dysfunction: Report of the definition and classification subcommittee. Investig. Ophthalmol. Vis. Sci. 2011;52:1930–1937. - PMC - PubMed
    1. Geerling G, et al. The international workshop on meibomian gland dysfunction: Report of the subcommittee on management and treatment of meibomian gland dysfunction. Investig. Ophthalmol. Vis. Sci. 2011;52:2050–2064. - PMC - PubMed
    1. Greiner JV. A single LipiFlow® thermal pulsation system treatment improves meibomian gland function and reduces dry eye symptoms for 9 months. Curr. Eye Res. 2012;37:272–278. - PubMed
    1. Freedman HL, Preston KL. Heat retention in varieties of warm compresses: A comparison between warm soaks, hard-boiled eggs and the re-heater. Ophthalmic Surg. 1989;20:846–848. - PubMed

Publication types